Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19)

Journal of Pediatric Rehabilitation Medicine(2020)10.3233/prm-200756Source: DataRank Database

A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19) is a research paper published in Journal of Pediatric Rehabilitation Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.08)OA: closedTopics (39)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Mark T. Fisher,Sathya Vadivelu,Justin Ramsey,Denesh Ratnasingam,Emily McGhee ORCID

Live enrichment

PubMed:33252098 OpenAlex:https://openalex.org/W3107574472

NICHD NIH HHS

Grant: K12 HD093427

NICHD NIH HHS

Grant: T32 HD069038

FWCI

0.08

Citation Percentile

0.5%

Citation Trend

2021

2024

closed

publisherhttps://content.iospress.com/download?id=10.3233/PRM-200756

journalhttps://doi.org/10.3233/prm-200756

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33252098

Fields of Study

Botulinum Toxin and Related Neurological DisordersCerebral Palsy and Movement DisordersStroke Rehabilitation and Recovery

MeSH Terms

Personal Protective EquipmentCOVID-19Cerebral PalsyChildDose-Response Relationship, DrugDrug Administration ScheduleHumansInjections, IntramuscularNeuromuscular AgentsRetrospective StudiesUnited StatesCase-Control StudiesInfectious Disease Transmission, Patient-to-ProfessionalPatient SelectionBotulinum Toxins, Type AVulnerable PopulationsPandemics

Keywords

Coronavirus disease 2019 (COVID-19)DosingMedicinePandemicCerebral palsyAmbulatory2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Emergency medicinePediatricsIntensive care medicinePhysical therapyVirologyInternal medicineDiseaseBotulinum toxinsAdverse EventsDrug-related Side Effects And Adverse ReactionsCovid-19

Sustainable Development Goals

SDG 0: Good health and well-being